02 Why Prednisolone Stays on the Prescription Pad: The Clinical Case Against Switching to Alternatives
When patients ask their doctors about switching to newer biologics or alternative immunosuppressants, the answer is often a firm but nuanced 'not yet.' Understanding why prednisolone remains a cornerstone of inflammatory and autoimmune treatment—despite the availability of newer options—requires a closer look at pharmacology, practicality, and cost. This article breaks down the clinical reasoning that keeps prednisolone on the prescription pad.